Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes
Clinical trial NCT00399711 · COMPLETED
Trial details
- NCT number
- NCT00399711
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2007-11-01
- Enrollment
- 560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.